AlphaMark Advisors’s Tenon Medical TNON Stock Holding History

AlphaMark Advisors’s Portfolio TNON Stock Details TNON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$0	Hold	50	–	–	﹤0.01%	727
2024 Q3	$0	Buy	+50	New	+$241	﹤0.01%	813

Other funds holding TNON

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaMark Advisors's TNON Position: Q4 2024 in Review

AlphaMark Advisors held its Tenon Medical (TNON) position steady in Q4 2024 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #727.

AlphaMark Advisors first reported a position in TNON in Q3 2024 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold TNON as of Q4 2024.

AlphaMark Advisors held 50 shares of Tenon Medical worth $0 as of Q4 2024.
AlphaMark Advisors left its Tenon Medical share count unchanged in Q4 2024.
Tenon Medical made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #727 holding.
AlphaMark Advisors first reported a position in Tenon Medical in Q3 2024 and has held it in 2 quarters since.
12 funds tracked by Wall St. Rank held Tenon Medical as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.